PAYS.NASDAQPaysign, INC

Form 4: Paysign CFO Granted 100K Restricted Stock, Filing Delayed

Sentiment:

Insider Transaction Report


Paysign, Inc.'s Chief Financial Officer, Jeffery Bradford Baker, was granted 100,000 shares of restricted common stock, vesting over three years, as reported in a delayed SEC Form 4 filing.

Delay expectedThe Form 4 was filed on September 26, 2025, reporting a transaction that occurred on May 7, 2025.This filing date is significantly beyond the two-business-day requirement for Section 16(a) reports, indicating a substantial delay in regulatory disclosure.

Summary

  • Jeffery Bradford Baker, Chief Financial Officer of Paysign, Inc. (PAYS), was granted 100,000 shares of common stock.
  • The transaction date for this grant was May 7, 2025.
  • The shares are restricted stock, meaning they are subject to a vesting schedule.
  • The vesting schedule dictates that 1/3 of the shares will vest on May 29, 2026, another 1/3 on May 20, 2027, and the final 1/3 on May 30, 2028.
  • Vesting is contingent upon Mr. Baker's continued service to Paysign, Inc. through each applicable vesting date.
  • The acquisition price for these shares was $0.000, indicating a grant rather than a purchase.
  • Following this transaction, Mr. Baker beneficially owns 352,273 shares of Paysign, Inc. common stock.
  • The Form 4 reporting this transaction was filed on September 26, 2025.

Sentiment

Score: 6

Explanation: The grant itself is a positive for management alignment and retention. However, the significant delay in filing the Form 4 introduces a negative element related to regulatory compliance, slightly tempering the overall sentiment.

Positives

  • The grant of restricted stock aligns the Chief Financial Officer's long-term interests with those of Paysign's shareholders.
  • This compensation structure serves as an incentive for executive retention and continued performance.

Negatives

  • The grant of 100,000 shares represents a minor potential future dilution for existing shareholders upon vesting.
  • The significant delay in filing the Form 4 (over four months after the transaction date) raises concerns regarding timely regulatory compliance.

Risks

  • The vesting of the restricted stock is subject to the reporting person's continued service to the issuer through and on the applicable vesting dates, posing a risk to the recipient if employment ceases.
  • The late filing of the Form 4 could potentially lead to regulatory scrutiny or penalties for the company or the insider.

Industry Context

The grant of restricted stock to a Chief Financial Officer is a common practice in the financial services and technology industries for executive compensation, aiming to align management incentives with long-term shareholder value creation and ensure executive retention.

Comparison to Industry Standards

  • Granting restricted stock as part of executive compensation is a standard practice across various industries, including financial technology, to incentivize long-term performance and retention.
  • The vesting schedule over three years is typical for such grants, providing a sustained incentive for the executive's continued service.
  • The late filing of the Form 4, however, deviates from the standard regulatory expectation of filing within two business days of the transaction, which is a compliance concern.

Stakeholder Impact

  • Shareholders: Experience minor potential dilution upon vesting of the restricted shares, but benefit from increased alignment of the CFO's interests with long-term company performance.
  • Employees: The grant reinforces the company's commitment to executive compensation and retention strategies.
  • Regulatory Authorities: The delayed filing may draw attention from the SEC regarding compliance with Section 16(a) reporting requirements.

Next Steps

  • The company will continue to monitor the vesting conditions for the restricted stock.
  • The Chief Financial Officer will need to maintain continuous service to the issuer to realize the full benefit of the grant.

Key Dates

DateDescription
05/07/2025Date of earliest transaction (grant of restricted stock)
09/26/2025Date the Form 4 was signed and filed
05/29/2026First vesting date for 1/3 of the restricted shares
05/20/2027Second vesting date for 1/3 of the restricted shares
05/30/2028Third and final vesting date for 1/3 of the restricted shares

Recommendation

hold

This Form 4 filing details a routine executive compensation grant and does not provide new fundamental information that would significantly alter the investment thesis for Paysign, Inc. While the grant aligns management interests, the delayed filing is a minor compliance concern. Investors should consider broader financial performance and strategic developments rather than this single insider transaction for investment decisions.

Keywords

Paysign, PAYS, Jeffery Bradford Baker, Chief Financial Officer, Restricted Stock, Stock Grant, Insider Transaction, Form 4, Executive Compensation, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.